Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span. (Q38473905)
Jump to navigation
Jump to search
scientific article published on 14 August 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span. |
scientific article published on 14 August 2014 |
Statements
Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span (English)
Marwa Amer
Eman El-Ahwany
A F Awad
Nermen Abdel Gawad
Suher Zada
F M Abdel Tawab
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference